Critical Path Institute to convene drug development leaders at 2026 Global Impact Conference
Meeting Announcement
NUTRITION 2026 puts science in the spotlight as thousands of nutrition researchers and health professionals convene for the the annual flagship meeting of the American Society for Nutrition. Qualifying journalists are invited to join the action July 25–28 in National Harbor, Maryland, just outside Washington, D.C.
The loss of biological diversity is one of the greatest challenges of our time. At the fourth World Biodiversity Forum in Davos, leading biodiversity researchers are joining participants from politics, business, civil society and the arts to develop a common approach for biodiversity protection.
Join us in Florence, Italy for this year's Society for Experimental Biology (SEB) Annual Conference!
Dr. Avishek Adhikari and his team have discovered a small group of neurons in the midbrain that potently controls food-seeking. Dr. Adhikari will discuss these findings and what they may suggest about eating disorders in an upcoming webinar, “Neural Circuits Controlling Food-Seeking” on Tuesday, June 9, 2026, at 2:00 pm EDT. The webinar will be hosted by Jeffrey Borenstein, M.D., President & CEO of the Brain & Behavior Research Foundation and host of the Emmy®-nominated television series Healthy Minds.
Researchers from LSU’s Pennington Biomedical Research Center are scheduled to present their latest findings in diabetes research and treatment at the American Diabetes Association’s (ADA) flagship conference, the 86th annual Scientific Sessions, taking place June 5-8 in New Orleans.
The ADA’s Scientific Sessions is the world’s largest diabetes meeting, convening an expected audience of over 12,000 leading physicians, scientists, researchers and healthcare professionals from around the globe. The premier diabetes meeting will feature the latest scientific findings in diabetes and obesity. Leading experts will share findings from research on prevention, care and cures at the Ernest N. Morial Convention Center.
As antimicrobial resistance continues to threaten modern medicine, international experts will gather at Targeting Phage Therapy 2026 (Valencia, Spain, June 9–10, 2026) to address one of the most pressing questions in infectious disease research: how can phage therapy move from scientific promise to routine clinical practice?
The congress will bring together leading clinicians, researchers, regulators, biotechnology innovators and industry leaders to discuss the scientific, regulatory, manufacturing and clinical challenges shaping the future of bacteriophage-based therapies. Featuring 56 scientific communications, the meeting will explore personalized phage therapy, engineered phages, hospital implementation, GMP manufacturing, regulatory pathways and One Health applications. As antibiotic resistance continues to rise worldwide, the event aims to identify practical solutions that can accelerate the responsible integration of phage therapy into healthcare systems and improve patient access to innovative treatments.
Are ultra-processed foods actually good for you? What is the future for GLP-1 drugs like Ozempic and Wegovy? How did politics and industry influence the new Dietary Guidelines for Americans? What is causing the surge in the tickborne alpha-gal syndrome meat allergy and how can people protect themselves? These are just a few of today’s most pressing nutrition topics that more than 30 of the world’s leading nutrition experts will tackle at the 14th annual International Conference on Nutrition in Medicine, taking place in Washington, D.C., Aug. 13-15, 2026.